中西医结合治疗围绝经期综合征的临床证据综述
该研究针对围绝经期综合征(PS)定义了16个临床问题,检索多个数据库至2025年8月29日,纳入280项研究(5部指南/共识、38篇系统综述、237项随机对照试验),采用AGREE II、AMSTAR 2和ROBUST-RCT评价方法学质量。证据总结显示,针灸对比常规西药、口服中药联合西药对比单用西药在疗效和安全性上优于或等效。
要点
- 针灸和口服中药治疗PS证据丰富,部分中医疗法证据不足。
- 针灸对比常规西药、中药联合西药对比单用西药疗效与安全性优于或等效。
- 证据基础不一致、方法学缺陷及国际适用性有限削弱了整体证据质量。
核心结论
- 针灸及口服中药联合西药治疗PS均显示出潜在获益。
- 证据基础不一致、方法学缺陷及国际适用性有限削弱了当前发现的整体质量。
研究设计与样本
- 研究定义了16个PS相关的临床问题与结局指标。
- 检索CNKI、PubMed、Cochrane Library等数据库及网站,自建库至2025年8月29日。
- 纳入临床实践指南/共识、系统综述和随机对照试验,分别采用AGREE II、AMSTAR 2和ROBUST-RCT评价方法学质量。
- 共纳入280项研究,包括5部指南/共识、38篇系统综述和237项随机对照试验,其中84.6%为中国发表。
主要发现
- 针灸和口服中药证据丰富,部分中医疗法证据很少或没有。
- 不同研究类型的研究质量存在差异。
- 证据总结显示,针灸对比常规西药治疗在疗效和安全性上优于或等效。
- 口服中药联合西药对比单用西药在疗效和安全性上优于或等效。
临床怎么用
- 对于围绝经期综合征,可考虑针灸或口服中药联合西药作为治疗选择。
- 应关注不同中医干预措施证据基础的不一致性。
局限性
- 证据基础在不同干预措施间存在不一致性。
- 纳入研究存在方法学缺陷。
- 研究结果的国际适用性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perimenopausal Syndrome (PS) results from estrogen fluctuations due to ovarian dysfunction, leading to autonomic and neuropsychological symptoms. Existing therapeutic methods have certain limitations, and integrated Chinese-Western medicine (ICWM) treatment can achieve complementary advantages. METHODS: We defined 16 clinical questions and outcomes for PS and searched CNKI, PubMed, the Cochrane Library, and other databases and relevant websites from inception to August 29, 2025. Relevant clinical practice guidelines/consensus statements (CPGs/CSs), systematic reviews (SRs), and randomized controlled trials (RCTs) were included, and their methodological quality was apprised using AGREE II, AMSTAR 2, and ROBUST-RCT, respectively. Data synthesis and visualization were performed using Microsoft Excel 2021 and R. RESULTS: 280 studies (5 CPGs/CSs, 38 SRs, 237 RCTs) were included, of which 84.6% were Chinese publications. Acupuncture and oral Chinese herbal medicine (CHM) had abundant evidence, some Chinese Medicine interventions had little or no evidence, and study quality varied across types. Evidence summaries showed acupuncture versus conventional Western therapy and integrated oral CHM and western medication (WM) versus WM alone were superior or equivalent in efficacy and safety for PS. CONCLUSIONS: This study mainly assesses the available evidence on acupuncture and integrated oral CHM and WM interventions for PS. Both treatment strategies demonstrate potential benefits for PS. Nevertheless, inconsistencies in the evidence base across different interventions, methodological shortcomings, and limited international applicability weaken the overall quality of current findings. Future research should target these gaps to advance evidence-based, personalized ICWM strategies, improving outcomes for women with PS worldwide.
引用
- Yang R, Zhao J, Li H, et al. Clinical evidence on integrated Chinese-Western medicine for perimenopausal syndrome. Integr Med Res. 2026. PMID: 42318324. doi:10.1016/j.imr.2026.101357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。